Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-16-020965

President and CEO sold 9,801 shares at $30.00 ($294,030)

  • President and CEO acquired 9,801 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pomerantz Roger · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-05-24 Exercise or conversion : show line 1 in the form +9,801 $0.71 $6,959 193,493 D
2016-05-24 Sale : show line 2 in the form −9,801 $30.00 $294,030 183,692 D
Open-market sales · 9,801 sh · avg $30.00 · $294,030

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-05-24 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −9,801 $0.71 2024-08-07 9,801 1,362,286 D
Loading xslF345X03/doc4.xml…